These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 24166226)

  • 1. Empirical performance of the self-controlled case series design: lessons for developing a risk identification and analysis system.
    Suchard MA; Zorych I; Simpson SE; Schuemie MJ; Ryan PB; Madigan D
    Drug Saf; 2013 Oct; 36 Suppl 1():S83-93. PubMed ID: 24166226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Empirical performance of a self-controlled cohort method: lessons for developing a risk identification and analysis system.
    Ryan PB; Schuemie MJ; Madigan D
    Drug Saf; 2013 Oct; 36 Suppl 1():S95-106. PubMed ID: 24166227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Empirical performance of the calibrated self-controlled cohort analysis within temporal pattern discovery: lessons for developing a risk identification and analysis system.
    Norén GN; Bergvall T; Ryan PB; Juhlin K; Schuemie MJ; Madigan D
    Drug Saf; 2013 Oct; 36 Suppl 1():S107-21. PubMed ID: 24166228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the empirical performance of methods for a risk identification system.
    Ryan PB; Stang PE; Overhage JM; Suchard MA; Hartzema AG; DuMouchel W; Reich CG; Schuemie MJ; Madigan D
    Drug Saf; 2013 Oct; 36 Suppl 1():S143-58. PubMed ID: 24166231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Empirical performance of the case-control method: lessons for developing a risk identification and analysis system.
    Madigan D; Schuemie MJ; Ryan PB
    Drug Saf; 2013 Oct; 36 Suppl 1():S73-82. PubMed ID: 24166225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Empirical performance of a new user cohort method: lessons for developing a risk identification and analysis system.
    Ryan PB; Schuemie MJ; Gruber S; Zorych I; Madigan D
    Drug Saf; 2013 Oct; 36 Suppl 1():S59-72. PubMed ID: 24166224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Replication of the OMOP experiment in Europe: evaluating methods for risk identification in electronic health record databases.
    Schuemie MJ; Gini R; Coloma PM; Straatman H; Herings RM; Pedersen L; Innocenti F; Mazzaglia G; Picelli G; van der Lei J; Sturkenboom MC
    Drug Saf; 2013 Oct; 36 Suppl 1():S159-69. PubMed ID: 24166232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detecting adverse drug reactions following long-term exposure in longitudinal observational data: The exposure-adjusted self-controlled case series.
    Schuemie MJ; Trifirò G; Coloma PM; Ryan PB; Madigan D
    Stat Methods Med Res; 2016 Dec; 25(6):2577-2592. PubMed ID: 24685766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Empirical performance of LGPS and LEOPARD: lessons for developing a risk identification and analysis system.
    Schuemie MJ; Madigan D; Ryan PB
    Drug Saf; 2013 Oct; 36 Suppl 1():S133-42. PubMed ID: 24166230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating performance of risk identification methods through a large-scale simulation of observational data.
    Ryan PB; Schuemie MJ
    Drug Saf; 2013 Oct; 36 Suppl 1():S171-80. PubMed ID: 24166233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Empirical assessment of methods for risk identification in healthcare data: results from the experiments of the Observational Medical Outcomes Partnership.
    Ryan PB; Madigan D; Stang PE; Overhage JM; Racoosin JA; Hartzema AG
    Stat Med; 2012 Dec; 31(30):4401-15. PubMed ID: 23015364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signal Detection for Recently Approved Products: Adapting and Evaluating Self-Controlled Case Series Method Using a US Claims and UK Electronic Medical Records Database.
    Zhou X; Douglas IJ; Shen R; Bate A
    Drug Saf; 2018 May; 41(5):523-536. PubMed ID: 29327136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of drug and outcome prevalence on the feasibility and performance of analytical methods for a risk identification and analysis system.
    Reich CG; Ryan PB; Suchard MA
    Drug Saf; 2013 Oct; 36 Suppl 1():S195-204. PubMed ID: 24166235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using Rich Data on Comorbidities in Case-Control Study Design with Electronic Health Record Data Improves Control of Confounding in the Detection of Adverse Drug Reactions.
    Backenroth D; Chase H; Friedman C; Wei Y
    PLoS One; 2016; 11(10):e0164304. PubMed ID: 27716785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of disproportionality safety signaling applied to healthcare databases.
    DuMouchel W; Ryan PB; Schuemie MJ; Madigan D
    Drug Saf; 2013 Oct; 36 Suppl 1():S123-32. PubMed ID: 24166229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Empirical assessment of case-based methods for identification of drugs associated with upper gastrointestinal bleeding in the French National Healthcare System database (SNDS).
    Thurin NH; Lassalle R; Schuemie M; Pénichon M; Gagne JJ; Rassen JA; Benichou J; Weill A; Blin P; Moore N; Droz-Perroteau C
    Pharmacoepidemiol Drug Saf; 2020 Aug; 29(8):890-903. PubMed ID: 32524701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of estimators from self-controlled case series, case-crossover design, and sequence symmetry analysis for pharmacoepidemiological studies.
    Takeuchi Y; Shinozaki T; Matsuyama Y
    BMC Med Res Methodol; 2018 Jan; 18(1):4. PubMed ID: 29310575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Comparative Assessment of Observational Medical Outcomes Partnership and Mini-Sentinel Common Data Models and Analytics: Implications for Active Drug Safety Surveillance.
    Xu Y; Zhou X; Suehs BT; Hartzema AG; Kahn MG; Moride Y; Sauer BC; Liu Q; Moll K; Pasquale MK; Nair VP; Bate A
    Drug Saf; 2015 Aug; 38(8):749-65. PubMed ID: 26055920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple self-controlled case series for large-scale longitudinal observational databases.
    Simpson SE; Madigan D; Zorych I; Schuemie MJ; Ryan PB; Suchard MA
    Biometrics; 2013 Dec; 69(4):893-902. PubMed ID: 24117144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative outcome definitions and their effect on the performance of methods for observational outcome studies.
    Reich CG; Ryan PB; Schuemie MJ
    Drug Saf; 2013 Oct; 36 Suppl 1():S181-93. PubMed ID: 24166234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.